MDVs to the rescue: How autophagy-deficient cancer cells adapt to defective mitophagy

Laura Poillet-Perez1, Eileen White2

  • 1Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm, CNRS, Toulouse, France.

Developmental Cell
|July 27, 2021
PubMed

Insights

Cancer cells rely on mitochondria and autophagy for survival. Researchers discovered mitochondria-derived vesicles (MDVs) as a novel mechanism that helps cancer cells maintain mitochondrial function when autophagy is impaired.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Mitochondrial Biology

Background:

  • Mitochondria are crucial for cancer cell energy production.
  • Autophagy is essential for maintaining mitochondrial quality and function.
  • Cancer cells often exhibit altered metabolic pathways, including mitochondrial dynamics and turnover.

Purpose of the Study:

  • To identify novel adaptive mechanisms cancer cells employ to maintain mitochondrial function.
  • To investigate the role of mitochondria-derived vesicles (MDVs) in cancer cell adaptation.
  • To understand how cancer cells compensate for impaired autophagy.

Main Methods:

  • Utilized advanced microscopy techniques to visualize and track MDVs.
  • Employed genetic and pharmacological approaches to manipulate autophagy and MDV formation.
  • Assessed mitochondrial function and cell viability under different experimental conditions.

Main Results:

  • Identified mitochondria-derived vesicles (MDVs) as a previously unrecognized cellular mechanism.
  • Demonstrated that MDVs facilitate the transport of mitochondrial components.
  • Showed that MDVs enable cancer cells to compensate for autophagy loss, preserving mitochondrial function and promoting cell survival.

Conclusions:

  • Mitochondria-derived vesicles (MDVs) represent a new adaptive strategy for cancer cells.
  • MDVs play a critical role in maintaining mitochondrial homeostasis, particularly under stress conditions like autophagy deficiency.
  • Targeting MDV formation could represent a novel therapeutic strategy in cancer treatment.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.7K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.6K